1 |
Lee, S. E., Woo, K. M., Kim, S. Y., Kim, H. M., Kwack, K., Lee, Z. H., and Kim, H. H., The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone, 30, 71-77 (2002)
|
2 |
Mundy, G., Bone remodeling, In Favus, M. J. (Eds). Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott Williams & Wilkins, Philadelphia, pp. 30-38 (1999)
|
3 |
Ryu, S. Y., No, Z. S., Kim, S. H., and Ahn, J. W., Two novel abietane diterpenes from Salvia miltorrhiza. Planta Med., 63, 44-46 (1997)
DOI
ScienceOn
|
4 |
Tang, W. and Eisenbrand, G., Chinese drugs of plant origin, Berlin, Springer-Verlag, (1992)
|
5 |
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., and Martin, T. J., Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev., 20, 345-357 (1999)
DOI
ScienceOn
|
6 |
Takeshita, S., Kaji, K., and Kudo, A., Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res., 15, 1477-1488 (2000)
DOI
ScienceOn
|
7 |
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., and Galibert, L. A., Homologue of the TNF receptor and its ligand enhance T-cell growth and dendriticcell function. Nature, 390, 175-195 (1997)
DOI
PUBMED
ScienceOn
|
8 |
Lee, Z. H. and Kim, H. H., Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem. Biophys. Res. Commun., 305, 211-214 (2003)
DOI
ScienceOn
|
9 |
Lacey, D. L., Tan, H. L., Lu, J., Kaufman, S., Van, G., Qiu, W., Rattan, A., Scully, S., Fletcher, F., Juan, T., Kelley, M., Burgess, T. L., Boyle, W. J., and Polverino, A. J., Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am. J. Pathol., 157, 435-48 (2000)
DOI
ScienceOn
|
10 |
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S. I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahash, N., and Suda, T., Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and identical to TRANCE-RANKL. Proc. Natl. Acad. Sci. U.S.A., 95, 3579-3602 (1998)
DOI
|
11 |
Tezuka, Y., Kasimu, R., Basnet, P., Namba, T., and Kadota S., Aldose reductase inhibitory constituents of the root of Salvia miltiorhiza BUNGE. Chem. Pharm. Bull., 45, 1306-1311 (1997)
DOI
ScienceOn
|
12 |
Lee, S. E., Chung, W. J., Kwack, H. B., Chung, C. H., Kwack, K., Lee, Z. H., and Kim, H. H., Tumor necrosis factor- supports the survival of osteoclasts through the activation of Akt and ERK. J. Biol. Chem., 276, 49343-49349 (2001)
DOI
ScienceOn
|
13 |
Harrison, L. J. and Asakawa, Y., 18-Oxoferruginol from the leaf of Torreya nucifera. Phytochemistry, 26, 1211-1212 (1987)
DOI
ScienceOn
|
14 |
Miyamoto, T., Arai, F., Ohneda, O., Takagi, K., Anderson, D. M., and Suda, T., An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Blood, 96, 4335-4343 (2000)
|